European Society for Medical Oncology

Making equal access to cancer treatment a priority

Access to treatment and care is a fundamental right of any patient. Yet despite the fast rate of new agent development, there are still astounding inequalities in the availability of and accessibility to cancer medications ...

Feb 04, 2015
popularity 7 comments 0

Immunotherapy set to revolutionise cancer treatment

Immunotherapy is set to revolutionise the treatment of cancer, according to ESMO President Professor Rolf A. Stahel. His comments come as the ESMO Symposium on Immuno-Oncology 2014 is about to open in Geneva, Switzerland ...

Nov 21, 2014
popularity 0 comments 0

New data on combination treatments for melanoma

Combination therapy with both BRAF inhibitor vemurafenib and MEK inhibitor cobimetinib achieves greater progression-free survival and response rates than vemurafenib plus placebo in BRAF-mutation positive melanoma, according ...

Sep 29, 2014
popularity 0 comments 0